Carda Health Appoints Chief Medical Officer Peter Antall to Lead Clinical Expansion

Digital health veteran joins to scale clinical infrastructure and deepen Carda’s tech-enabled recovery model for patients with chronic heart and lung disease

Carda Health, a leader in at-home virtual pulmonary and cardiac care, announced the appointment of Peter Antall, M.D., as Chief Medical Officer (CMO). Dr. Antall joins Carda to help scale the company’s clinical capabilities and infrastructure, ensuring the platform can meet the growing national demand for high-quality, home-based cardiopulmonary rehabilitation.

In this new role, Dr. Antall will lead a clinical team of more than 120 professionals, and work closely with the company’s clinical leads and physicians. His appointment comes at a pivotal moment as Carda moves from a high-growth startup to a premier clinical platform capable of supporting millions of patients.

The addition of Dr. Antall brings added credibility and strengthens Carda’s ability to scale its digital care model while maintaining the clinical quality and outcomes for which it is well-known. His experience building and scaling programs at Amwell, Brightline and others, as well as his deep expertise in health tech innovation provides a proven roadmap for expanding access to care while ensuring exceptional results.

"We didn’t just need a Chief Medical Officer; we needed someone who understands that technology should be an engine that powers our clinicians, not another barrier that stands between them and their patients," said Harry DiFrancesco, Co-founder & CEO of Carda Health. "Peter has scaled platforms to thousands of providers. He shares our belief that the way to fix care is to use technology to enable better, richer interactions between patients and clinicians instead of putting the burden on either group to complete endless, friction-filled tasks. His leadership will be a catalyst for us to reach millions of people who are not able to access traditional rehab."

As the healthcare industry grapples with rising costs and provider burnout, Carda’s proven ability to expand access to cardiopulmonary rehabilitation and ability to drive down the cost of care while reducing hospital readmissions by 40% makes it a vital partner for Medicare health plans and providers nationwide.

"Carda is solving one of the hardest problems in healthcare: that of making lifestyle change permanent," said Dr. Peter Antall. "Most digital tools may offer temporary fixes, but they usually fail to sustain engagement in the long term and fail to achieve meaningful outcomes.. I joined Carda because they have demonstrated success in enrolling and engaging patients into a set of programs that meaningfully improve care and change outcomes.. I’m looking forward to working with Carda’s exceptional clinical team to ensure that this best-in-class care is made available to as many patients as possible.."

For more information on Carda Health, visit Cardahealth.com.

About Carda Health

Carda Health is the leading virtual care company transforming how patients recover from chronic diseases, with a focus on heart and lung disease. Through its proprietary digital platform, Carda delivers clinically proven home-based rehabilitation (HBCR) and chronic care programs. Each program combines one-on-one sessions with live monitored exercise, including real-time vitals measurements. Through these sessions, Carda enables patients to rebuild their strength and overall health safely from home while reducing readmissions. Carda Health partners with health plans and provider groups nationwide to expand access to evidence-based, cost-saving chronic care programs for members who face barriers to traditional rehab. Founded in 2020, Carda Health is redefining recovery through technology, compassion, and convenience.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  211.71
+6.34 (3.09%)
AAPL  252.41
+4.42 (1.78%)
AMD  205.35
+4.02 (2.00%)
BAC  47.91
+0.75 (1.58%)
GOOG  299.65
+0.86 (0.29%)
META  607.41
+13.75 (2.32%)
MSFT  385.02
+3.15 (0.82%)
NVDA  176.84
+4.14 (2.39%)
ORCL  154.15
+4.47 (2.99%)
TSLA  382.21
+14.25 (3.87%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.